Skip to main content
. 2023 Dec 21;18(12):e0294067. doi: 10.1371/journal.pone.0294067

Fig 3. Effect of FO (Gp IV) and FO-SLNs (Gp V) on antioxidant biomarkers, MAPK and TGF-β pathways.

Fig 3

A; superoxide dismutase (SOD) activity (U/ g tissue), B; catalase (CAT) activity (U/ g tissue), C; protein kinase RNA-like endoplasmic reticulum kinase (pERK), D; Phosphorylated Jun N- Terminal Kinase (pJNK), E; phosphorylated p38 (pp38), F; The m-RNA expression of transforming growth factor beta (TGF-β). In comparison with the normal control group (Gp I), UVB group (Gp II) and the positive standard group (Gp III). Data are presented as mean ±SD for 6 rats. *Statistically significant difference from normal control group (p˂0.0001), #statistically significant difference from the UVB group (p˂0.0001), @statistically significant difference from the positive standard group (Vitamin A palmitate) (p˂0.0001), $statistically significant difference from FO (unformulated frankincense oil) group (p˂0.0001).